Shenzhen Xbiome Biotech Co.
Latest round
- Series B
Last raised
- Dec 2021
Total raised
- $100M
Investors
- 12
About Shenzhen Xbiome Biotech Co.
, Ltd. operates as an artificial intelligence pharmaceutical company focuses on intestinal drug development. The core team is from Harvard University, Massachusetts Institute of Technology, Stanford University, Johns Hopkins University. The company is mainly engaged in the mitigation or treatment of intestinal and other systemic diseases through fecal bacteria transplantation, formula bacteria and other microbial treatment methods.
Who invested in Shenzhen Xbiome Biotech Co.
12 investors across 5 rounds
See all investors in Shenzhen Xbiome Biotech Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shenzhen Xbiome Biotech Co.
Who invested in Shenzhen Xbiome Biotech Co.?
Shenzhen Xbiome Biotech Co. has 12 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shenzhen Xbiome Biotech Co. raised?
Shenzhen Xbiome Biotech Co. has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Shenzhen Xbiome Biotech Co. last raise money?
Shenzhen Xbiome Biotech Co.'s most recent round on record is a Series B, in Dec 2021.
What does Shenzhen Xbiome Biotech Co. do?
Shenzhen Xbiome Biotech Co. is a biotechnology company.
Where is Shenzhen Xbiome Biotech Co. headquartered?
Shenzhen Xbiome Biotech Co. is headquartered in Shenzhen, China.
Which VCs invest in companies like Shenzhen Xbiome Biotech Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Shenzhen Xbiome Biotech Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Shenzhen Xbiome Biotech Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.